Canada markets closed

FSD Pharma Inc. (0K9A.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.8860+0.0030 (+0.34%)
At close: 05:54PM CET
Full screen
Previous Close0.8830
Open0.8790
Bid0.8120 x N/A
Ask0.8490 x N/A
Day's Range0.8700 - 0.8860
52 Week Range0.8120 - 4.3220
Volume175
Avg. Volume791
Market Cap36.666M
Beta (5Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-0.9990
Earnings DateMar. 15, 2022 - Mar. 21, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    FSD Pharma Announces Launch of New Corporate Website

    TORONTO, January 20, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company’s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. To vi

  • Business Wire

    FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada

    TORONTO, January 18, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, warmly congratulates Eleanor N. Fish, Ph.D., a member of its Research and Clinical Advisory Board, on her appointment to the Order of Canada.

  • Business Wire

    FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th

    TORONTO, January 04, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that Anthony Durkacz, Interim CEO of FSD Pharma, will present at the H.C. Wainwright Bioconnect Conference to be held virtually on January 10-13, 2022. Mr. Durkacz’s presentation will be available on-demand for conference attendees starting at 7:00 a.m. ET on January 10